Entrust Financial’s Avanos Medical AVNS Stock Holding History

Entrust Financial’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-25	Closed	-$622	–	516
2026 Q2	$622	Hold	25	–	–	﹤0.01%	435
2026 Q1	$351	Hold	25	–	–	﹤0.01%	425
2025 Q4	$281	Buy	+25	New	+$286	﹤0.01%	413

Other funds holding AVNS

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Bayban Bayport, Minnesota $130M AUM 21.7% 1-Year Est. Return

Entrust Financial's AVNS Position: Q3 2026 in Review

Entrust Financial sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 25 shares — an estimated $622 sold.

Entrust Financial first reported a position in AVNS in Q4 2025 and held it in 3 quarters. The position peaked at $622 in Q2 2026. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

Entrust Financial reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
Entrust Financial sold 25 Avanos Medical shares in Q3 2026, an estimated $622.
Entrust Financial first reported a position in Avanos Medical in Q4 2025 and held it in 3 quarters.
Entrust Financial's Avanos Medical position peaked at $622 in Q2 2026.
3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Entrust Financial's 13F filing for Q3 2026, filed 4 Nov 2026.